Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-25 @ 2:04 AM
NCT ID:
NCT06861660
Eligibility Criteria:
Inclusion Criteria:
* Student is 17-20 years of age
* Student is an LMU incoming first-year college student
* Student has access to a cellular device capable of receiving text messages
* Student's parent or legal guardian has an email address on file at LMU
* Student's parent or legal guardian has a cellular device capable of receiving text messages
* Student's parent or legal guardian received an invitation from the research team to participate
* Student's parent or legal guardian signed up to access the assigned intervention
* Student's parent or legal guardian is a resident of the United States
* Informed consent (or assent, as applicable) is provided
Exclusion Criteria:
* Student is not 17-20 years of age
* Student is not an LMU incoming first-year college student
* Student does not have access to a cellular device capable of receiving text messages
* Student's parent or legal guardian does not have an email address on file at LMU
* Student's parent or legal guardian does not have a cellular device capable of receiving text messages
* Student's parent or legal guardian did not receive an invitation from the research team to participate
* Student's parent or legal guardian did not sign up to access the assigned intervention
* Student's parent or legal guardian is not a resident of the United States
* Informed consent (or assent, as applicable) is not provided
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
17 Years
Maximum Age:
20 Years
Study:
NCT06861660
Study Brief:
Protocol Section:
NCT06861660